1. A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Issue 12 (2nd December 2018) Authors: de Jong, Jan; Hellemans, Peter; De Wilde, Severijn; Patricia, Daniel; Masterson, Tara; Manikhas, Georgii; Myasnikov, Alexander; Osmanov, Dzhelil; Córdoba, Raúl; Panizo, Carlos; de Zwart, Loeckie; Snoeys, Jan; Chauhan, Vijay; Jiao, James; Sukbuntherng, Juthamas; Ouellet, Daniele Journal: Leukemia & lymphoma Issue: Volume 59:Issue 12(2018) Page Start: 2888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023) Authors: Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants. Issue 4 (24th June 2015) Authors: de Jong, Jan; Skee, Donna; Murphy, Joe; Sukbuntherng, Juthamas; Hellemans, Peter; Smit, Johan; de Vries, Ronald; Jiao, Juhui James; Snoeys, Jan; Mannaert, Erik Journal: Pharmacology research & perspectives Issue: Volume 3:Issue 4(2015:Aug.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants. Issue 4 (24th June 2015) Authors: de Jong, Jan; Skee, Donna; Murphy, Joe; Sukbuntherng, Juthamas; Hellemans, Peter; Smit, Johan; de Vries, Ronald; Jiao, Juhui James; Snoeys, Jan; Mannaert, Erik Journal: Pharmacology research & perspectives Issue: Volume 3:Issue 4(2015:Aug.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants. Issue 4 (24th June 2015) Authors: de Jong, Jan; Skee, Donna; Murphy, Joe; Sukbuntherng, Juthamas; Hellemans, Peter; Smit, Johan; de Vries, Ronald; Jiao, Juhui James; Snoeys, Jan; Mannaert, Erik Journal: Pharmacology research & perspectives Issue: Volume 3:Issue 4(2015:Aug.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6. Issue 5 (18th September 2020) Authors: de Jong, Jan; Mitselos, Anna; Jurczak, Wojciech; Cordoba, Raul; Panizo, Carlos; Wrobel, Tomasz; Dlugosz‐Danecka, Monika; Jiao, James; Sukbuntherng, Juthamas; Ouellet, Daniele; Hellemans, Peter Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 5(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma. Issue 7 (2nd July 2016) Authors: Moreau, Philippe; Facon, Thierry; Touzeau, Cyrille; Benboubker, Lotfi; Delain, Martine; Badamo-Dotzis, Julie; Phelps, Charles; Doty, Christopher; Smit, Hans; Fourneau, Nele; Forslund, Ann; Hellemans, Peter; Leleu, Xavier Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment*. Issue 1 (2nd January 2017) Authors: de Jong, Jan; Skee, Donna; Hellemans, Peter; Jiao, James; de Vries, Ronald; Swerts, Dominique; Lawitz, Eric; Marbury, Thomas; Smith, William; Sukbuntherng, Juthamas; Mannaert, Erik Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults. (15th January 2016) Authors: de Vries, Ronald; Smit, Johan W.; Hellemans, Peter; Jiao, James; Murphy, Joseph; Skee, Donna; Snoeys, Jan; Sukbuntherng, Juthamas; Vliegen, Maarten; de Zwart, Loeckie; Mannaert, Erik; de Jong, Jan Journal: British journal of clinical pharmacology Issue: Volume 81:Number 2(2016:Feb.) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗